Skip to content
Screener

Pre-Tax Income at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-$25.65M-23.8%
UnitedHealth Group logo
UnitedHealth GroupUNH
$6.97B+70.7%
Conduent Incorporated logo
Conduent IncorporatedCNDT
-$57M-32.6%
Definitive Healthcare Corp. logo
Definitive Healthcare Corp.DH
-$7.8M+11.5%
Corvel logo
CorvelCRVL
$43.34M+22.8%
Phreesia logo
PhreesiaPHR
$4.72M+249%

Segments

By segment

See full
Reportable Segment-$76.65M+7.6%

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%
EPS (diluted)-$3.49+8.4%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Reported directly by Claritev Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: Claritev Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001793229-26-000067
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest income(195)(323)(377)(811)
Transaction costs related to refinancing transaction877,879
Loss on extinguishment of debt670
Net loss before taxes(76,649)(82,932)(169,370)(172,800)
Benefit for income taxes(17,423)(20,292)(36,584)(38,841)
Net loss(59,226)(62,640)(132,786)(133,959)
Less: net loss attributable to non-controlling interests
Net loss attributable to Claritev Corporation$(59,226)$(62,640)$(132,786)$(133,959)

Item 1. Financial Statements

FAQ

What is Claritev Corporation's pre-tax income?
Claritev Corporation (CTEV) reported pre-tax income of -$76.65M in Q2 2026.
How has Claritev Corporation's pre-tax income changed year-over-year?
Claritev Corporation's pre-tax income increased by 7.6% year-over-year, from -$82.93M to -$76.65M.
What is the long-term trend for Claritev Corporation's pre-tax income?
Over 4 years (2021 to 2025), Claritev Corporation's pre-tax income has grown at a 28.8% compound annual growth rate (CAGR), from $135.45M to -$373.08M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about Claritev Corporation's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude